Clinical trialNCT05161429UnknownObservational

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

SponsorBrigham and Women's HospitalEnrollment550,000Diabetes Mellitus, Type 2

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

An observational study of electronic patient data to compare diabetes medications and to determine which ones offer the best balance of risks and benefits.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Alexander Turchin, MD, MS
Brigham and Women's Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Healthcore, Inc.
Wilmington, Delaware, United States
Recruiting
Humana
Lexington, Kentucky, United States
Recruiting
Brigham and Women'S Hospital
Boston, Massachusetts, United States
Recruiting
Greater Plains Collaborative
Beachwood, Ohio, United States
Recruiting
Baylor Scott & White
Dallas, Texas, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Basal InsulinDPP4GLP-1 receptor agonistSLGT2

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Jul 2021
Primary completion: 30 Jun 2024
Completion: 30 Jun 2024
Last update posted: 22 Jun 2023
Registered enrollment: 550,000
Registry id: NCT05161429

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.